{"schema_version":"1","generated_at":"2026-11-05T05:55:47.880Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-xiong","json_url":"https://www.findmykol.com/kol/david-xiong/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-xiong","name":"David Xiong","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1598386575","orcid":"0000-0003-4990-8063","openalex":"A5002959016"},"summary":"David Xiong is a Dermatology physician affiliated with Cleveland Clinic. OpenAlex indexes 41 publications with 1,306 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":41,"cited_by_count":1306,"h_index":14,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":114.38,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598386575"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":23.93,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598386575"},{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":18.64,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598386575"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1598386575","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":53.3,"classes_total":2,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":40.2,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":34},{"class":"Lincosamide Antibacterial","setting":"prescribed","share_pct":13.1,"drugs":[{"name":"Clindamycin Phosphate","share_pct":100}],"max_beneficiaries":12}]},{"area":"Dermatology","share_pct":31.1,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":31.1,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":27}]},{"area":"Sensory organs","share_pct":15.6,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":15.6,"drugs":[{"name":"Clobetasol Propionate","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":41,"shown":5,"withheld":36,"matched_by":"OpenAlex author record","recent":[{"title":"73423 Psoriasis epidemiology in patients with inflammatory bowel disease: A National Health Interview Survey Study","year":2026,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2026.04.1427","status":"verified"},{"title":"The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: A retrospective national cohort study","year":2023,"journal":"Journal of the American Academy of Dermatology","source_url":"https://doi.org/10.1016/j.jaad.2023.08.040","status":"verified"},{"title":"Incidence and Survival Outcomes of Dermatofibrosarcoma Protuberans From 2000 to 2020: A Population-Based Retrospective Cohort Analysis","year":2023,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/dss.0000000000004018","status":"verified"},{"title":"Analysis of Survival Differences Between Cutaneous and Subcutaneous Malignant Peripheral Nerve Sheath Tumors","year":2023,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/dss.0000000000003717","status":"verified"},{"title":"Racial–Ethnic, Education, and Socioeconomic Differences in the Treatment of Head and Neck Melanoma in situ: A Surveillance Epidemiology and End Results Population-Based Analysis","year":2023,"journal":"Dermatologic Surgery","source_url":"https://doi.org/10.1097/dss.0000000000004005","status":"verified"}],"source":"works"},"contact":{"address_1":"2049 E 100TH ST DEPT OF","city":"Cleveland","state":"OH","zip":"441062104","phone":"216-844-3178","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1598386575","source":"identity"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Joel Gelfand","slug":"joel-gelfand","institution":"University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/joel-gelfand","json_url":"https://www.findmykol.com/kol/joel-gelfand/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":36}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-08-02","provider_certified":"2024-08-02","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}